Overview

Study to Assess the Effect of Gabapentin Enacarbil on Simulated Driving in Healthy Subjects

Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
This is a double-blind, placebo-and active-controlled 3-period crossover study designed to assess the effect of GEn 600 mg on simulated driving performance in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
XenoPort, Inc.
Treatments:
Diphenhydramine
Gabapentin
gamma-Aminobutyric Acid
Promethazine